GSK PLC's ticker is and the CUSIP is 37733W204. A total of 715 filers reported holding GSK PLC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,154,150 | +64.5% | 107,900 | +83.2% | 0.15% | +84.3% |
| Q1 2024 | $2,525,043 | +88373.8% | 58,900 | -23.5% | 0.08% | +13.7% |
| Q4 2023 | $2,854 | -1.2% | 77,000 | -3.4% | 0.07% | -39.7% |
| Q3 2023 | $2,889 | +11.3% | 79,700 | +9.5% | 0.12% | -13.6% |
| Q2 2023 | $2,595 | -99.7% | 72,800 | +141.1% | 0.14% | +60.9% |
| Q3 2022 | $889,000 | – | 30,200 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |